Verapamil Hydrochloride
- Product NDC
- 43353-921
- 11-digit product format
- 433530921
- Labeler code
- 43353
- Product ID
- 43353-921_31d4ff90-aca0-45e6-ae5e-8e5bacc16970
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA074587
- Marketing category
- ANDA
- Marketing start
- 2014-12-04
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-921-16 | 43353092116 | 6000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43353-921-16) | 2014-12-06 | 0000-00-00 | No | No | Current |